Signatera is the newest, fully personalized molecular genetic test for monitoring solid tumours

The Signatera test is a custom-designed test generated based on each patient’s unique set of tumour mutations.

There are no two identical tumours, therefore there are no two identical Signatera tests either.

Early detection of tumour progression or recurrence can provide significant support to your doctor in choosing the right therapy for you.

The Signatera test is applicable to all solid tumours, with the exception of brain tumours and haematological tumours.